Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Cancer research 57 , 42294235 (1997)
Its 39-residue sequence is engineered around a GIP backbone rather than the more commonly modified GLP-1 scaffold, a design choice that fundamentally shapes its receptor pharmacology and distinguishes it from earlier dual-agonist candidates that simply chained GLP-1 and glucagon sequences together
Hanmi Pharmaceuticals announced a global licensing agreement for sonefpeglutide, a long-acting GLP-2 analog built on its proprietary LAPSCOVERY platform
Electrolyte drinks, like sports drinks, can be useful after heavy sweating or bouts of nausea
US$ 29.96
US$ 23.47
US$ 28.81
US$ 28.09
US$ 24.40
